Use Cases

Discover real-life applications and white papers showcasing ImmuneWatch’s DETECT and DESIGN technologies in immune monitoring and vaccine design.

August 22, 2024

ImmuneWatch DETECT Assists in Uncovering the Role of CMV in T-Cell Leukemia

Recently, our DETECT tool played a role in research conducted by Dr. Utpal Davé, Associate Professor at Indiana University School of Medicine, aimed at understanding T-cell large granular lymphocytic leukemia (T-LGL).

Watch the Video

July 31, 2024

T-Cell Monitoring in Cancer Vaccine Research

This poster showcased how ImmuneWatch DETECT is used for T-cell monitoring in cancer vaccine research, featuring a case study of a stage IV colorectal cancer patient.

Download the Poster

January 11, 2024

New white paper on TCR sequencing for cancer vaccine developers

To know the efficacy of your cancer vaccine, it is crucial to analyse the T cell response. Because of its versatility, TCR sequencing is a rising tool to monitor such immune responses. However, the full potential of TCR sequencing remains unrealised at present.

Download the Whitepaper

April 21, 2023

Release of our Reverse Vaccinology white paper

Are you looking to implement AI in your vaccine development process? Meet reverse vaccinology: An AI-driven procedure that allows vaccinologists to determine potential vaccine targets in a faster, cheaper, and more sustainable fashion.

Download the Whitepaper

December 16, 2021

ImmuneWatch releases white paper evaluating the effect of mutations gathered in the SARS-COV-2 Omicron variant on T cell immunity

Omicron, the latest SARS-COV-2 variant of concern is characterized by a large number of mutations. In our first white paper, we evaluate the effect of these mutations on T-cell immunity by applying a T-cell receptor (TCR)/epitope interaction model.

Download the Whitepaper